These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 8724787

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
    Eckert S, Eyer P, Mückter H, Worek F.
    Biochem Pharmacol; 2006 Jul 28; 72(3):344-57. PubMed ID: 16780806
    [Abstract] [Full Text] [Related]

  • 3. [Aminostigmine as a cholinesterase inhibitor and as an agent for treating poisonings by cholinergic blockers].
    Prozorovskiĭ VB, Livanov GA, Velikova VD, Afanas'ev VV, Pavlova LV.
    Eksp Klin Farmakol; 1994 Jul 28; 57(5):13-5. PubMed ID: 7696893
    [Abstract] [Full Text] [Related]

  • 4. [The pharmacological characteristics of the new anticholinesterase drug aminostigmine].
    Prozorovskiĭ VB, Pavlova LV, Suslova IM, Shchemeleva NI.
    Eksp Klin Farmakol; 1992 Jul 28; 55(1):13-6. PubMed ID: 1305425
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The toxicological characteristics of the interaction of cholinolytics with aminostigmine--a new reversible cholinesterase inhibitor].
    Prozorovskiĭ VB, Sazonova AV.
    Eksp Klin Farmakol; 1995 Jul 28; 58(5):57-61. PubMed ID: 8704593
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the decarbamylation process of cholinesterase during assay of enzyme activity.
    Rotenberg M, Almog S.
    Clin Chim Acta; 1995 Sep 15; 240(2):107-16. PubMed ID: 8548921
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors.
    Herkert NM, Eckert S, Eyer P, Bumm R, Weber G, Thiermann H, Worek F.
    Toxicology; 2008 Apr 18; 246(2-3):188-92. PubMed ID: 18304715
    [Abstract] [Full Text] [Related]

  • 11. [Histamine blockers increase efficacy of specific antidote prophylaxis of intoxication by cholinesterase inhibitors in mice].
    Prozorovskiĭ VB, Skopichev VG, Ditiateva ZhA, Sazonova AV.
    Eksp Klin Farmakol; 2000 Apr 18; 63(4):64-7. PubMed ID: 11022312
    [Abstract] [Full Text] [Related]

  • 12. [Acceleration of the restoration of conditioned reflexes following anesthesia using aminostigmine].
    Prozorovskiĭ VB, Iudkina NI.
    Anesteziol Reanimatol; 1991 Apr 18; (1):25-6. PubMed ID: 1862957
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the oxime-induced reactivation of erythrocyte and muscle acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity.
    Eckert S, Eyer P, Herkert N, Bumm R, Weber G, Thiermann H, Worek F.
    Biochem Pharmacol; 2008 Feb 01; 75(3):698-703. PubMed ID: 17977518
    [Abstract] [Full Text] [Related]

  • 14. Reactivation and aging kinetics of human acetylcholinesterase inhibited by organophosphonylcholines.
    Worek F, Thiermann H, Szinicz L.
    Arch Toxicol; 2004 Apr 01; 78(4):212-7. PubMed ID: 14647978
    [Abstract] [Full Text] [Related]

  • 15. Effects of oximes on rate of decarbamylation of human red blood cell AChE measured with two different methods.
    Eckert S, Eyer P, Melzer M, Thiermann H, Worek F.
    Biochem Pharmacol; 2008 Apr 01; 75(7):1561-6. PubMed ID: 18281016
    [Abstract] [Full Text] [Related]

  • 16. Abnormal cholinesterase activity: understanding and interpretation.
    Jokanović M, Maksimović M.
    Eur J Clin Chem Clin Biochem; 1997 Jan 01; 35(1):11-6. PubMed ID: 9156559
    [Abstract] [Full Text] [Related]

  • 17. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon.
    Petroianu GA, Arafat K, Kuca K, Kassa J.
    J Appl Toxicol; 2006 Jan 01; 26(1):64-71. PubMed ID: 16193529
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro oxime-assisted reactivation of paraoxon-inhibited human acetylcholinesterase and butyrylcholinesterase.
    Musilova L, Kuca K, Jung YS, Jun D.
    Clin Toxicol (Phila); 2009 Jul 01; 47(6):545-50. PubMed ID: 19586353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.